About
2.65USD+0.12 +4.74%
Closed • Updated at 13:37 GMT+00:00Market Cap$49.26M
Volume88.9K
Beta3.01
RSI21.14
Kala Bio, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
KALA BIO Announces Reverse Stock Split
Apr 28 2026
Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
Apr 21 2026
Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
Apr 1 2026
Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
Mar 30 2026
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
Google Übersetzer